These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28889299)

  • 21. Three-dimensional structure of a mycobacterial oligoribonuclease reveals a unique C-terminal tail that stabilizes the homodimer.
    Badhwar P; Khan SH; Taneja B
    J Biol Chem; 2022 Dec; 298(12):102595. PubMed ID: 36244449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Based Comparison of Cyclic Di-GMP Signaling in Pathogenic and Commensal Escherichia coli Strains.
    Povolotsky TL; Hengge R
    J Bacteriol; 2016 Jan; 198(1):111-26. PubMed ID: 26303830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NrnA Is a Linear Dinucleotide Phosphodiesterase with Limited Function in Cyclic Dinucleotide Metabolism in Listeria monocytogenes.
    Gall AR; Hsueh BY; Siletti C; Waters CM; Huynh TN
    J Bacteriol; 2022 Jan; 204(1):e0020621. PubMed ID: 34662239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of fluorescent biosensor for cyclic di-GMP.
    Ho CL; Koh SL; Chuah ML; Luo Z; Tan WJ; Low DK; Liang ZX
    Chembiochem; 2011 Dec; 12(18):2753-8. PubMed ID: 22021215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of c-di-GMP Levels Synthesized by a Photoreceptor Protein in Response to Different Light Qualities Using an In Vitro Enzymatic Assay.
    Angerer V; Essen LO; Wilde A
    Methods Mol Biol; 2017; 1657():187-204. PubMed ID: 28889295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fluorescence-based high-throughput screening method for determining the activity of diguanylate cyclases and c-di-GMP phosphodiesterases.
    Wang ZQ; Xuan TF; Liu J; Chen WM; Lin J
    RSC Adv; 2020 May; 10(33):19482-19489. PubMed ID: 35515470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterases and cyclic GMP regulation in heart muscle.
    Lee DI; Kass DA
    Physiology (Bethesda); 2012 Aug; 27(4):248-58. PubMed ID: 22875455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type IV Pili-Dependent Motility as a Tool to Determine the Activity of c-di-GMP Modulating Enzymes in Myxococcus xanthus.
    Skotnicka D; Søgaard-Andersen L
    Methods Mol Biol; 2017; 1657():157-165. PubMed ID: 28889293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of proton wires in the enzyme active site suggests a mechanism of c-di-GMP hydrolysis by the EAL domain phosphodiesterases.
    Grigorenko BL; Knyazeva MA; Nemukhin AV
    Proteins; 2016 Nov; 84(11):1670-1680. PubMed ID: 27479508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
    Beltman J; Becker DE; Butt E; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
    Mol Pharmacol; 1995 Feb; 47(2):330-9. PubMed ID: 7870041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
    Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
    J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains.
    Schmidt AJ; Ryjenkov DA; Gomelsky M
    J Bacteriol; 2005 Jul; 187(14):4774-81. PubMed ID: 15995192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering Selective Diguanylate Cyclase Inhibitors: From PleD to Discrimination of the Active Site of Cyclic-di-GMP Phosphodiesterases.
    Rinaldo S; Giardina G; Mantoni F; Paiardini A; Paone A; Cutruzzolà F
    Methods Mol Biol; 2017; 1657():431-453. PubMed ID: 28889312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2'-F-c-di-GMP.
    Zhou J; Watt S; Wang J; Nakayama S; Sayre DA; Lam YF; Lee VT; Sintim HO
    Bioorg Med Chem; 2013 Jul; 21(14):4396-404. PubMed ID: 23685177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic Di-GMP Signaling Contributes to Pseudomonas aeruginosa-Mediated Catheter-Associated Urinary Tract Infection.
    Cole SJ; Lee VT
    J Bacteriol; 2016 Jan; 198(1):91-7. PubMed ID: 26195591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterases (PDEs): coincidence detectors acting to spatially and temporally integrate cyclic nucleotide and non-cyclic nucleotide signals.
    Maurice DH; Wilson LS; Rampersad SN; Hubert F; Truong T; Kaczmarek M; Brzezinska P; Freitag SI; Umana MB; Wudwud A
    Biochem Soc Trans; 2014 Apr; 42(2):250-6. PubMed ID: 24646226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A blue light-inducible phosphodiesterase activity in the cyanobacterium Synechococcus elongatus.
    Cao Z; Livoti E; Losi A; Gärtner W
    Photochem Photobiol; 2010; 86(3):606-11. PubMed ID: 20408974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed analysis of c-di-GMP mediated regulation of csgD expression in Salmonella typhimurium.
    Ahmad I; Cimdins A; Beske T; Römling U
    BMC Microbiol; 2017 Feb; 17(1):27. PubMed ID: 28148244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The second messenger bis-(3'-5')-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa.
    Merighi M; Lee VT; Hyodo M; Hayakawa Y; Lory S
    Mol Microbiol; 2007 Aug; 65(4):876-95. PubMed ID: 17645452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.